Bryn Mawr Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.86M | Sell |
55,228
-1,215
| -2% | -$84.9K | 0.21% | 100 |
|
|
2025
Q1 | $4.15M | Sell |
56,443
-1,130
| -2% | -$83.1K | 0.25% | 94 |
|
|
2024
Q4 | $3.77M | Sell |
57,573
-100
| -0.2% | -$6.55K | 0.2% | 107 |
|
|
2024
Q3 | $4.49M | Sell |
57,673
-1,110
| -2% | -$86.5K | 0.24% | 90 |
|
|
2024
Q2 | $4.58M | Sell |
58,783
-2,508
| -4% | -$196K | 0.25% | 91 |
|
|
2024
Q1 | $4.15M | Sell |
61,291
-575
| -0.9% | -$39K | 0.24% | 96 |
|
|
2023
Q4 | $4.17M | Buy |
61,866
+164
| +0.3% | +$11K | 0.26% | 90 |
|
|
2023
Q3 | $4.18M | Sell |
61,702
-726
| -1% | -$49.2K | 0.27% | 81 |
|
|
2023
Q2 | $4.47M | Sell |
62,428
-365
| -0.6% | -$26.1K | 0.42% | 59 |
|
|
2023
Q1 | $4.36M | Sell |
62,793
-3,100
| -5% | -$215K | 0.45% | 61 |
|
|
2022
Q4 | $4.47M | Buy |
+65,893
| New | +$4.47M | 0.48% | 59 |
|